Drug Shortage Report for TARO-CEFPROZIL

Last updated on 2024-02-14 History
Report ID 169495
Drug Identification Number 02293579
Brand name TARO-CEFPROZIL
Common or Proper name CEFPROZIL
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) CEFPROZIL
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 75
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-09
Estimated end date 2023-10-06
Actual end date 2023-10-16
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v36 2024-02-14 English Compare
v35 2023-10-25 French Compare
v34 2023-10-25 English Compare
v33 2023-09-22 French Compare
v32 2023-09-22 English Compare
v31 2023-08-16 French Compare
v30 2023-08-16 English Compare
v29 2023-07-18 French Compare
v28 2023-07-18 English Compare
v27 2023-05-08 French Compare
v26 2023-05-08 English Compare
v25 2023-04-28 French Compare
v24 2023-04-28 English Compare
v23 2023-04-10 French Compare
v22 2023-04-10 English Compare
v21 2023-03-24 French Compare
v20 2023-03-24 English Compare
v19 2023-03-10 French Compare
v18 2023-03-10 English Compare
v17 2023-02-01 French Compare

Showing 1 to 20 of 36